Roles of RIPK3 in necroptosis, cell signaling, and disease

참고문헌 (191)

1. Verma, I., "2002 Nobel Prize for physiology and medicine", Mol. Ther, 6, pp.698~ (2002)
2. Galluzzi, L., "Molecular mechanisms of cell death : recommendations of the Nomenclature Committee on Cell Death 2018", Cell Death Differ, 25, pp.486~541 (2018)
3. Sun, X., "RIP3, a novel apoptosis-inducing kinase", J. Biol. Chem, 274, pp.16871~16875 (1999)
4. Yu, P. W., "Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB", Curr. Biol, 9, pp.539~542 (1999)
5. Kasof, G. M., "The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria", FEBS Lett, 473, pp.285~291 (2000)
6. Grooten, J., "Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity : early events in tumour necrosis factor-induced cytotoxicity", Cytokine, 5, pp.546~555 (1993)
7. Vercammen, D., "Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor", J. Exp. Med, 187, pp.1477~1485 (1998)
8. Holler, N., "Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule", Nat. Immunol, 1, pp.489~495 (2000)
9. Laster, S. M., "Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis", J. Immunol, 141, pp.2629~2634 (1988)
10. Denecker, G., "Death receptor-induced apoptotic and necrotic cell death : differential role of caspases and mitochondria", Cell Death Differ, 8, pp.829~840 (2001)
11. Degterev, A., "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury", Nat. Chem. Biol, 1, pp.112~119 (2005)
12. Lin, Y., "Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation", J. Biol. Chem, 279, pp.10822~10828 (2004)
13. Cho, Y. S., "Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation", Cell, 137, pp.1112~1123 (2009)
14. He, S., "Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha", Cell, 137, pp.1100~1111 (2009)
15. Zhang, D. W., "RIP3, an energy metabolism regulator that switches TNFinduced cell death from apoptosis to necrosis", Science, 325, pp.332~336 (2009)
16. Morgan, M., "Programmed cell death with a necrotic-like phenotype", Biomol. Concepts, 4, pp.259~275 (2013)
17. Vanlangenakker, N., "Many stimuli pull the necrotic trigger, an overview", Cell Death Differ, 19, pp.75~86 (2012)
18. Kroemer, G., "Classification of cell death: recommendations of the Nomenclature Committee on Cell Death", Cell Death Differ, 12(Suppl 2), pp.1463~1467 (2005)
19. Fiers, W., "More than one way to die : apoptosis, necrosis and reactive oxygen damage", Oncogene, 18, pp.7719~7730 (1999)
20. Kaczmarek, A., "Necroptosis : the release of damage-associated molecular patterns and its physiological relevance", Immunity, 38, pp.209~223 (2013)
21. Choi, M. E., "Necroptosis: a crucial pathogenic mediator of human disease", JCI Insight, 4, pp.1~16 (2019)
22. Gong, Y. -N., "ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences", Cell, 169, pp.286~300 (2017)
23. Zhu, K., "Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression", Cell Death Dis, 9, pp.500~ (2018)
24. Orozco, S. L., "RIPK3 activation leads to cytokine synthesis that continues after loss of cell membrane integrity", Cell Rep, 28, pp.2275~2287.e2275 (2019)
25. Yatim, N., "RIPK1 and NF-kappaB signaling in dying cells determines crosspriming of CD8(+)T cells", Science, 350, pp.328~334 (2015)
26. Snyder, A. G., "Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity", Sci. Immunol, 4, pp.1~16 (2019)
27. Park, H. H., "RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment", Mol. Cancer, 20, pp.107~ (2021)
28. Aaes, T. L., "Vaccination with necroptotic cancer cells induces efficient antitumor immunity", Cell Rep, 15, pp.274~287 (2016)
29. Zhao, J., "Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis", Proc. Natl Acad. Sci. USA, 109, pp.5322~5327 (2012)
30. Sun, L., "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase", Cell, 148, pp.213~227 (2012)
31. Wu, J. F., "Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis", Cell Res, 23, pp.994~1006 (2013)
32. Murphy, J. M., "The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism", Immunity, 39, pp.443~453 (2013)
33. Hildebrand, J. M., "Activation of the pseudokinase MLKL unleashes the fourhelix bundle domain to induce membrane localization and necroptotic cell death", Proc. Natl Acad. Sci. USA, 111, pp.15072~15077 (2014)
34. Li, L., "The molecular mechanisms of MLKLdependent and MLKL-independent necrosis", J. Mol. Cell Biol, 13, pp.3~14 (2021)
35. Chen, W., "Diverse sequence determinants control human and mouse receptor interacting protein 3(RIP3)and mixed lineage kinase domain-like(MLKL)interaction in necroptotic signaling", J. Biol. Chem, 288, pp.16247~16261 (2013)
36. Petrie, E. J., "Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis", Nat. Commun, 9, pp.2422~ (2018)
37. Huang, D., "The MLKL channel in necroptosis is an octamer formed by tetramers in a dyadic process", Mol. Cell Biol, 37, pp.1~17 (2017)
38. Wang, H. Y., "Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3", Mol. Cell, 54, pp.133~146 (2014)
39. Dondelinger, Y., "MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates", Cell Rep, 7, pp.971~981 (2014)
40. Quarato, G., "Sequential engagement of distinct MLKL phosphatidylinositolbinding sites executes necroptosis", Mol. Cell, 61, pp.589~601 (2016)
41. Dovey, C. M., "MLKL requires the inositol phosphate code to execute necroptosis", Mol. Cell, 70, pp.936~948.e937 (2018)
42. Xia, B., "MLKL forms cation channels", Cell Res, 26, pp.517~528 (2016)
43. Ros, U., "Necroptosis execution is mediated by plasma membrane nanopores independent of calcium", Cell Rep, 19, pp.175~187 (2017)
44. Cai, Z. Y., "Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis", Nat. Cell Biol, 16, pp.55~ (2014)
45. Chen, X., "Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death", Cell Res, 24, pp.105~121 (2014)
46. Vandenabeele, P., "Molecular mechanisms of necroptosis : an ordered cellular explosion", Nat. Rev. Mol. Cell Biol, 11, pp.700~714 (2010)
47. Galluzzi, L., "Essential versus accessory aspects of cell death : recommendations of the NCCD 2015", Cell Death Differ, 22, pp.58~73 (2015)
48. Schock, S. N., "Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway", Cell Death Differ, 24, pp.615~625 (2017)
49. Robinson, N., "Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium", Nat. Immunol, 13, pp.954~962 (2012)
50. Brault, M., "Intracellular nucleic acid sensing triggers necroptosis through synergistic type I IFN and TNF signaling", J. Immunol, 200, pp.2748~2756 (2018)
51. Sun, X., "Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein(RIP)by RIP3", J. Biol. Chem, 277, pp.9505~9511 (2002)
52. Devin, A., "The role of the death-domain kinase RIP in tumournecrosis-factor-induced activation of mitogen-activated protein kinases", EMBO Rep, 4, pp.623~627 (2003)
53. Degterev, A., "Identification of RIP1 kinase as a specific cellular target of necrostatins", Nat. Chem. Biol, 4, pp.313~321 (2008)
54. Petrie, E. J., "The structural basis of necroptotic cell death signaling", Trends Biochem. Sci, 44, pp.53~63 (2019)
55. Li, J., "The RIP1", RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis, 2012, pp.150, 339~350
56. Mompean, M., "The structure of the necrosome RIPK1-RIPK3 core, a human hetero-amyloid signaling complex", Cell, 173, pp.1244~1253.e1210 (2018)
57. Orozco, S., "RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis", Cell Death Differ, 21, pp.1511~1521 (2014)
58. Lin, Y., "Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis", Genes Dev, 13, pp.2514~2526 (1999)
59. Feng, S., "Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain", Cell. Signal, 19, pp.2056~2067 (2007)
60. O’Donnell, M. A., "Caspase 8 inhibits programmed necrosis by processing CYLD", Nat. Cell Biol, 13, pp.1437~1442 (2011)
61. Michael J. Morgan, "Reactive Oxygen Species in TNF alpha-Induced Signaling and Cell Death", Molecules and Cells, 30(1), pp.1~12 (2010), 한국분자세포생물학회
62. Rickard, J. A., "RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis", Cell, 157, pp.1175~1188 (2014)
63. Dillon, C. P., "RIPK1 blocks early postnatal lethality mediated by caspase-8and RIPK3", Cell, 157, pp.1189~1202 (2014)
64. Dannappel, M., "RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis", Nature, 513, pp.90~94 (2014)
65. Bonnet, M. C., "The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation", Immunity, 35, pp.572~582 (2011)
66. Ch’en, I. L., "Mechanisms of necroptosis in T cells", J. Exp. Med, 208, pp.633~641 (2011)
67. Dillon, C. P., "Survival function of the FADD-CASPASE-8-cFLIP(L)complex", Cell Rep, 1, pp.401~407 (2012)
68. Kaiser, W. J., "RIP3 mediates the embryonic lethality of caspase-8-deficient mice", Nature, 471, pp.368~372 (2011)
69. Lu, J. V., "Complementary roles of Fas-associated death domain(FADD)and receptor interacting protein kinase-3(RIPK3)in T-cell homeostasis and antiviral immunity", Proc. Natl Acad. Sci. USA, 108, pp.15312~15317 (2011)
70. Moulin, M., "IAPs limit activation of RIP kinases by TNF receptor 1 during development", EMBO J, 31, pp.1679~1691 (2012)
71. Oberst, A., "Catalytic activity of the caspase-8-FLIP(L)complex inhibits RIPK3-dependent necrosis", Nature, 471, pp.363~367 (2011)
72. Zhang, H. B., "Functional complementation between FADD and RIP1 in embryos and lymphocytes", Nature, 471, pp.373~376 (2011)
73. Pobezinskaya, Y. L., "The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors", Nat. Immunol, 9, pp.1047~1054 (2008)
74. Ermolaeva, M. A., "Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses", Nat. Immunol, 9, pp.1037~1046 (2008)
75. Chen, N. J., "Beyond tumor necrosis factor receptor: TRADD signaling in tolllike receptors", Proc. Natl Acad. Sci. USA, 105, pp.12429~12434 (2008)
76. Haas, T. L., "Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction", Mol. Cell, 36, pp.831~844 (2009)
77. Fullsack, S., "Redundant and receptorspecific activities of TRADD, RIPK1 and FADD in death receptor signaling", Cell Death Dis, 10, pp.122~ (2019)
78. Seo Jinho, "Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators", Experimental and Molecular Medicine, 53, pp.1~11 (2021), 생화학분자생물학회[DOI]
79. Wertz, I. E., "De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling", Nature, 430, pp.694~699 (2004)
80. Wright, A., "Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD", Dev. Cell, 13, pp.705~716 (2007)
81. Heger, K., "OTULIN limits cell death and inflammation by deubiquitinating LUBAC", Nature, 559, pp.120~124 (2018)
82. Annibaldi, A., "Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2", Mol. Cell, 69, pp.566~580.e565 (2018)
83. Chen, M., "Smac mimetic promotes TNF-alpha to induce apoptosis of gallbladder carcinoma cells", Cell. Signal, 72, pp.109654~ (2020)
84. Dondelinger, Y., "Serine 25 phosphorylation inhibits RIPK1 kinasedependent cell death in models of infection and inflammation", Nat. Commun, 10, pp.1729~ (2019)
85. Xu, D., "TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging", Cell, 174, pp.1477~1491.e1419 (2018)
86. Tenev, T., "The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs", Mol. Cell, 43, pp.432~448 (2011)
87. Feoktistova, M., "cIAPs block Ripoptosome formation, a RIP1", caspase-8containing intracellular cell death complex differentially regulated by cFLIP isoforms, 2011, pp.43, 449~463
88. Amin, P., "Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFalpha-mediated apoptosis", Proc. Natl Acad. Sci. USA, 115, pp.E5944~E5953 (2018)
89. Wang, H., "PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP", Proc. Natl Acad. Sci. USA, 114, pp.11944~11949 (2017)
90. Seo, J., "CHIP controls necroptosis through ubiquitylation-and lysosomedependent degradation of RIPK3", Nat. Cell Biol, 18, pp.291~302 (2016)
91. Choi, S. W., "PELI1 selectively targets kinase-active RIP3 for ubiquitylationdependent proteasomal degradation", Mol. Cell, 70, pp.920~935.e927 (2018)
92. Michael J. Morgan, "The serine threonine kinase RIP3: lost and found", BMB Reports, 48(6), pp.303~312 (2015), 생화학분자생물학회
93. Seong, D., "Identification of MYC as an antinecroptotic protein that stifles RIPK1-RIPK3 complex formation", Proc. Natl Acad. Sci. USA, 117, pp.19982~19993 (2020)
94. Xie, Y., "Inhibition of aurora kinase A induces necroptosis in pancreatic carcinoma", Gastroenterology, 153, pp.1429~1443.e1425 (2017)
95. Chen, W., "Ppm1b negatively regulates necroptosis through dephosphorylating Rip3", Nat. Cell Biol, 17, pp.434~444 (2015)
96. Lee, S. Y., "Casein kinase-1gamma1 and 3 stimulate tumor necrosis factorinduced necroptosis through RIPK3", Cell Death Dis, 10, pp.923~ (2019)
97. Hanna-Addams, S., "CK1alpha, CK1delta, and CK1epsilon are necrosome components which phosphorylate serine 227 of human RIPK3 to activate necroptosis", Proc. Natl Acad. Sci. USA, 117, pp.1962~1970 (2020)
98. Kim, Y. S., "TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death", Mol. Cell, 26, pp.675~687 (2007)
99. Yazdanpanah, B., "Riboflavin kinase couples TNF receptor 1 to NADPH oxidase", Nature, 460, pp.1159~1163 (2009)
100. Vanden Berghe, T., "Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features", Cell Death Differ, 17, pp.922~930 (2010)
101. Goossens, V., "Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity", Proc. Natl Acad. Sci. USA, 92, pp.8115~8119 (1995)
102. Yang, Z., "RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis", Nat. Cell Biol, 20, pp.186~197 (2018)
103. Tait, S. W., "Widespread mitochondrial depletion via mitophagy does not compromise necroptosis", Cell Rep, 5, pp.878~885 (2013)
104. Zhang, Y., "RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome", Nat. Commun, 8, pp.14329~ (2017)
105. Paulsen, C. E., "Orchestrating redox signaling networks through regulatory cysteine switches", ACS Chem. Biol, 5, pp.47~62 (2010)
106. Groen, A., "Differential oxidation of protein-tyrosine phosphatases", J. Biol. Chem, 280, pp.10298~10304 (2005)
107. Nakashima, I., "Redox-linked signal transduction pathways for protein tyrosine kinase activation", Antioxid. Redox Signal, 4, pp.517~531 (2002)
108. Nakashima, I., "Redox control of catalytic activities of membrane-associated protein tyrosine kinases", Arch. Biochem. Biophys, 434, pp.3~10 (2005)
109. Kamata, H., "Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases", Cell, 120, pp.649~661 (2005)
110. Yeh, W. C., "FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis", Science, 279, pp.1954~1958 (1998)
111. Lawrence, C. P., "FADD deficiency sensitises Jurkat T cells to TNFalpha-dependent necrosis during activation-induced cell death", FEBS Lett, 579, pp.6465~6472 (2005)
112. Geserick, P., "Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment", J. Cell Biol, 187, pp.1037~1054 (2009)
113. Vanlangenakker, N., "cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1", RIP3-dependent reactive oxygen species production, 2011, pp.18, 656~665
114. Bohgaki, T., "Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-", -mice, 2011, pp.195, 277~291
115. Dondelinger, Y., "RIPK3 contributes to TNFR1-mediated RIPK1 kinasedependent apoptosis in conditions of cIAP1", 2 depletion or TAK1 kinase inhibition, 2013, pp.20, 1381~1392
116. Morioka, S., "TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP", Oncogene, 28, pp.2257~2265 (2009)
117. Goodall, M. L., "The autophagy machinery controls cell death switching between apoptosis and necroptosis", Dev. Cell, 37, pp.337~349 (2016)
118. Sprick, M. R., "FADD", MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2, 2000, pp.12, 599~609
119. Kuang, A. A., "FADD is required for DR4-and DR5-mediated apoptosis : lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts", J. Biol. Chem, 275, pp.25065~25068 (2000)
120. Peter, M. E., "The TRAIL DISCussion: It is FADD and caspase-8!", Cell Death Differ, 7, pp.759~760 (2000)
121. Jouan-Lanhouet, S., "TRAIL induces necroptosis involving RIPK1", RIPK3-dependent PARP-1 activation, 2012, pp.19, 2003~2014
122. Meurette, O., "TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions", Cancer Res, 67, pp.218~226 (2007)
123. Henry, C. M., "Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory “FADDosome” complex upon TRAIL stimulation", Mol. Cell, 65, pp.715~729.e715 (2017)
124. Cao, X., "The role of TRADD in TRAILinduced apoptosis and signaling", FASEB J, 25, pp.1353~1358 (2011)
125. Kim, J. Y., "TRADD is critical for resistance to TRAIL-induced cell death through NF-kappaB activation", FEBS Lett, 585, pp.2144~2150 (2011)
126. Lafont, E., "The linear ubiquitin chain assembly complex regulates TRAILinduced gene activation and cell death", EMBO J, 36, pp.1147~1166 (2017)
127. Simoes Eugenio, M., "TRIM21, a new component of the TRAIL-induced endogenous necrosome complex", Front. Mol. Biosci, 8, pp.645134~ (2021)
128. Jin, Z., "Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis", Mol. Cell Biol, 26, pp.8136~8148 (2006)
129. Varfolomeev, E., "Molecular determinants of kinase pathway activation by Apo2 ligand", tumor necrosis factor-related apoptosis-inducing ligand, 2005, pp.280, 40599~40608
130. He, S., "Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway", Proc. Natl Acad. Sci. USA, 108, pp.20054~20059 (2011)
131. Lim, J., "Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins", Elife, 8, pp.e44452~ (2019)
132. Rebsamen, M., "The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases", Cell Death Differ, 15, pp.1804~1811 (2008)
133. McComb, S., "cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation", Cell Death Differ, 19, pp.1791~1801 (2012)
134. McComb, S., "Cathepsins limit macrophage necroptosis through cleavage of Rip1 kinase", J. Immunol, 192, pp.5671~5678 (2014)
135. Ariana, A., "Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4(TLR4)signaling in murine macrophages", J. Biol. Chem, 295, pp.4661~4672 (2020)
136. Kaiser, W. J., "Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL", J. Biol. Chem, 288, pp.31268~31279 (2013)
137. Bernard, J. J., "Ultraviolet radiation damages self noncoding RNA and is detected by TLR3", Nat. Med, 18, pp.1286~1290 (2012)
138. Weber, A., "Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells", Cell Death Differ, 17, pp.942~951 (2010)
139. Vercammen, E., "Sensing of viral infection and activation of innate immunity by toll-like receptor 3", Clin. Microbiol. Rev, 21, pp.13~25 (2008)
140. Jiao, H., "Z-nucleic-acid sensing triggers ZBP1-dependent necroptosis and inflammation", Nature, 580, pp.391~395 (2020)
141. Upton, J. W., "DAI", ZBP1, Cell Host Microbe, pp.2012, 11[DOI]
142. Maelfait, J., "Sensing of viral and endogenous RNA by ZBP1", DAI induces necroptosis, 2017, pp.36, 2529~2543
143. Nogusa, S., "RIPK3 activates parallel pathways of MLKL-driven necroptosis and FADD-mediated apoptosis to protect against influenza A virus", Cell Host Microbe, 20, pp.13~24 (2016)
144. Lin, J., "RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation", Nature, 540, pp.124~128 (2016)
145. Newton, K., "RIPK1 inhibits ZBP1-driven necroptosis during development", Nature, 540, pp.129~133 (2016)
146. Vince, J. E., "Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation", Immunity, 36, pp.215~227 (2012)
147. Kang, T. B., "Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome", Immunity, 38, pp.27~40 (2013)
148. Lawlor, K. E., "RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL", Nat. Commun, 6, pp.6282~ (2015)
149. Kang, S., "Caspase-8 scaffolding function and MLKL regulate NLRP3inflammasome activation downstream of TLR3", Nat. Commun, 6, pp.7515~ (2015)
150. Duong, B. H., "A20 restricts ubiquitination of pro-interleukin-1beta protein complexes and suppresses NLRP3 inflammasome activity", Immunity, 42, pp.55~67 (2015)
151. Speir, M., "RIP-roaring inflammation : RIPK1 and RIPK3 driven NLRP3inflammasome activation and autoinflammatory disease", Semin. Cell Dev. Biol, 109, pp.114~124 (2021)
152. Pazdernik, N. J., "Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB", Mol. Cell Biol, 19, pp.6500~6508 (1999)
153. Newton, K., "Kinase RIP3 is dispensable for normal NF-KBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and toll-like receptors 2 and 4", Mol. Cell Biol, 24, pp.1464~1469 (2004)
154. Moriwaki, K., "The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair", Immunity, 41, pp.567~578 (2014)
155. Orozco, S., "RIPK3 in cell death and inflammation : the good, the bad, and the ugly", Immunol. Rev, 277, pp.102~112 (2017)
156. Wu, X., "Investigation of receptor interacting protein(RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics", Mol. Cell Proteom, 11, pp.1640~1651 (2012)
157. Al-Moujahed, A., "Receptor interacting protein kinase 3(RIP3)regulates iPSCs generation through modulating cell cycle progression genes", Stem Cell Res, 35, pp.101387~ (2019)
158. Torii, S., "Identification of a phosphorylation site on Ulk1 required for genotoxic stress-induced alternative autophagy", Nat. Commun, 11, pp.1754~ (2020)
159. Koo, G. -B., "Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics", Cell Res, 25, pp.707~725 (2015)
160. Colbert, L. E., "Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma", Cancer, 119, pp.3148~3155 (2013)
161. Ertao, Z., "Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner", Tumour Biol, 37, pp.13679~13685 (2016)
162. Park, S., "The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma", Cancer Res, 69, pp.2809~2816 (2009)
163. Seifert, L., "The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression", Nature, 532, pp.245~249 (2016)
164. Conev, N. V., "RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer", Clin. Invest. Med, 42, pp.E31~E38 (2019)
165. Wang, W., "RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer", Cancer Cell, 34, pp.757~774.e757 (2018)
166. Jiao, D., "Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis", Cell Res, 28, pp.868~870 (2018)
167. Strilic, B., "Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis", Nature, 536, pp.215~218 (2016)
168. Linkermann, A., "Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury", Proc. Natl Acad. Sci. USA, 110, pp.12024~12029 (2013)
169. Lin, J., "A role of RIP3-mediated macrophage necrosis in atherosclerosis development", Cell Rep, 3, pp.200~210 (2013)
170. Meng, L., "RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality", Proc. Natl Acad. Sci. USA, 112, pp.11007~11012 (2015)
171. Kaiser, W. J., "Viral modulation of programmed necrosis", Curr. Opin. Virol, 3, pp.296~306 (2013)
172. DeRoo, E., "The role of RIPK1 and RIPK3 in cardiovascular disease", Int. J. Mol. Sci, 21, pp.8174~ (2020)
173. Piamsiri, C., "Targeting necroptosis as therapeutic potential in chronic myocardial infarction", J. Biomed. Sci, 28, pp.25~ (2021)
174. Khoury, M. K., "Necroptosis in the pathophysiology of disease", Am. J. Pathol, 190, pp.272~285 (2020)
175. Leng, Y., "Receptor interacting protein kinases 1", 3 : the potential therapeutic target for cardiovascular inflammatory diseases, 2021, pp.12, 762334~
176. Dai, W., "The potential role of necroptosis in clinical diseases(Review)", Int. J. Mol. Med, 47, pp.89~ (2021)
177. Faust, H., "Collateral damage: necroptosis in the development of lung injury", Am. J. Physiol. Lung Cell Mol. Physiol, 318, pp.L215~L225 (2020)
178. Wang, L., "Necroptosis in pulmonary diseases : a new therapeutic target", Front. Pharmacol, 12, pp.737129~ (2021)
179. Dara, L., "The receptor interacting protein kinases in the liver", Semin. Liver Dis, 38, pp.73~86 (2018)
180. Gautheron, J., "Lytic cell death in metabolic liver disease", J. Hepatol, 73, pp.394~408 (2020)
181. Li, X., "A narrative review of the role of necroptosis in liver disease : a double-edged sword", Ann. Transl. Med, 9, pp.422~ (2021)
182. Saeed, W. K., "Necroptosis signaling in liver diseases : an update", Pharmacol. Res, 148, pp.104439~ (2019)
183. Shojaie, L., "Cell death in liver diseases : a review", Int. J. Mol. Sci, 21, pp.9682~ (2020)
184. Yanez, M. J., "c-Abl activates RIPK3 signaling in Gaucher disease", Biochim. Biophys. Acta Mol. Basis Dis, 1867, pp.166089~ (2021)
185. Anders, H. J., "Necroptosis in acute kidney injury", Nephron, 139, pp.342~348 (2018)
186. Shi, Y., "RIPK3 : a new player in renal fibrosis", Front. Cell Dev. Biol, 8, pp.502~ (2020)
187. Uni, R., "Novel roles of necroptosis mediator receptor-interacting protein kinase 3 in kidney injury", Nephron, 146, pp.259~263 (2021)
188. Khan, I., "A decade of cell death studies : breathing new life into necroptosis", Pharmacol. Ther, 220, pp.107717~ (2021)
189. Yu, Z., "Necroptosis : a novel pathway in neuroinflammation", Front. Pharmacol, 12, pp.701564~ (2021)
190. Kim, S. K., "Upregulated RIP3 expression potentiates MLKL phosphorylationmediated programmed necrosis in toxic epidermal necrolysis", J. Invest. Dermatol, 135, pp.2021~2030 (2015)
191. Jeon, J., "TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis", Ann. Rheum. Dis, 79, pp.1635~1643 (2020)

관련 논문AI추천